BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GoingPublic.de - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.goingpublic.de
X-WR-CALDESC:Veranstaltungen für GoingPublic.de
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200526
DTEND;VALUE=DATE:20200529
DTSTAMP:20260529T220224
CREATED:20200406T145526Z
LAST-MODIFIED:20200430T135426Z
UID:108188-1590483600-1590656399@www.goingpublic.de
SUMMARY:6th Annual Digital Immuno-Oncology Innovation Forum
DESCRIPTION:-The event will be held online- \nWith the rapid spread of the coronavirus pandemic this is a timely review of the industry response to the crisis. Among the topics covered during the 6th Annual Immuno-Oncology Innovation Forum are revised development strategies and clinical trials\, as well as the challenge of finance and investment for biotechs. With the cancellation of the major industry conferences\, this digital event allows the IO community to be updated on the most recent developments and to network with colleagues from across the world using our online video meeting platform. We are keen to support our community and\, with the virtual conference\, can offer all the benefits attendees would usually expect. \nThe #Sachs_IOIF brings together leaders from cancer research institutes\, patient advocacy groups\, early and late-stage investors\, pharmas and biotechs. The programme will cover licensing and investment opportunities in the immuno-oncology field.
URL:https://www.goingpublic.de/event/6th-annual-digital-immuno-oncology-innovation-forum/
CATEGORIES:Life Sciences,Medienpartner
ATTACH;FMTTYPE=image/png:https://www.goingpublic.de/wp-content/uploads/2020/04/IOIF-Digital.png
END:VEVENT
END:VCALENDAR